N/A
Loading page data
Please wait a moment
Loading page data
Please wait a moment
Second Floor, 150 Fleet Street,
London, EC4A 2DQ.
+44 203-837-5656
108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018
+1 646-878-6329
IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.
+91 906 779 3500
Superaglottic ventilatory devices are a set of medical devices used for temporary airway management. These devices are inserted via the mouth and do not penetrate the larynx. They act as a passage for the administration of gases, ventilation and oxygenation. Superaglottic ventilatory devices have become a modern tool in anesthesiology and are replacing tracheal intubation.
Superaglottic ventilatory devices are gaining popularity due to their superior performance and higher patient safety. The offer less post-operative discomfort and high speed insertion when compared with other technologies. Superaglottic ventilatory devices deliver the oxygen and anesthesia above the vocal cords and thus, are less invasive for the respiratory tract.
Thus, the use of these devices ensures a relatively less sore throat, increases the ease of placement and reduces coughing. Superaglottic ventilatory devices are being used as alternatives for face masks and other airway devices.
The superaglottic ventilatory devices market is primarily driven by the vast patient pool comprising people suffering from respiratory diseases and respiratory arrest heart diseases, which can be attributed to the alarming pollution levels across the globe. Superaglottic ventilator devices are used for patients undergoing surgical procedures with anesthesia.
Superaglottic ventilatory devices are cost effective and efficient and also, reduce the need for additional anesthetic drugs. Moreover, these devices reduce patient complications and have been observes to facilitate faster recovery.
Technological advancements and sophistication in superaglottic ventilatory devices will drive the growth of the market. Superaglottic ventilatory devices are used as alternatives for the conventional methods of airway management, i.e. the endotracheal tube (ET) and face mask (FM). However, according to the Journal of Anesthesia & Clinical Research, some incidences of gastric insufflation have been reported.
| Based on product type |
|
| Based on technology |
|
| Based on end user |
|
Geographically, the superaglottic ventilatory devices market has been segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa and Japan. The market in North America, followed by Europe, is expected to dominate the global superaglottic ventilatory devices market. The North America market’s dominance can be attributed to the significant investments by the government and private sector, technological advancements and the focus on patient safety.
The market in Asia Pacific is expected to grow at a higher rate with growing incidences of respiratory diseases, arrests and increased prevalence of surgical procedures with anesthesia. With the rise in R&D projects in Asian countries such as Japan and Australia, the availability of superaglottic ventilatory devices will increase in the market over the forecast year. Moreover, superaglottic devices offer less post-operative discomfort and ease of insertion, which is surging their adoption in hospitals. Regions such as Asia Pacific and Latin America are expected to further spur revenue growth during the forecast period.
Some of the major players identified in the superaglottic ventilatory devices market are Medtronic, Smiths Medical, Teleflex, Ambu Karl Storz, Vyaire Medical and VBM Medizintechnik. Players are involved in collaboration agreements in order to exploit maximum potential and mainly focus on strengthening the core competencies of their product portfolio.
